Digestive Disease Week, May 18-21

Digestive Disease Week, the annual meeting sponsored by the American Association for the Study of Liver Diseases, American Gastroenterological Association, American Society for Gastrointestinal Endoscopy, and Society for Surgery of the Alimentary Tract, was held from May 18 to 21 in Washington, D.C., drawing more than 13,000 participants from around the world, including researchers and academics in the fields of gastroenterology, hepatology, endoscopy, and gastrointestinal surgery.

In one study, Yazan Abboud, M.D., of the Rutgers University New Jersey Medical School in Newark, and colleagues found that non-Hispanic Black patients have been experiencing an increase in the incidence of gallbladder cancer.

In a nationwide analysis covering nearly 98 percent of the U.S. population, Abboud and colleagues evaluated the medical records of 76,873 patients diagnosed with gallbladder cancer between 2001 and 2020 using the U.S. Cancer Statistics database.

The researchers found that minority patients of non-Hispanic Black race/ethnicity experienced an increase in gallbladder cancer incidence, on average, between 2001 and 2020 compared with other race/ethnic groups, who experienced a decline in incidence. In addition, many of the cases involved tumors diagnosed at an advanced stage.

“These findings help in understanding the epidemiology of gallbladder cancer and aim to guide future efforts to identify the contributions of the revealed racial/ethnic disparity,” Abboud said.

Press Release

In another study, Christopher McGowan, M.D., of True You Weight Loss in Cary, North Carolina, and colleagues found that endoscopic mucosal ablation of the gastric fundus is safe and effective and produces a statistically and clinically meaningful reduction in ghrelin, hunger, meal capacity, and weight.

In a six-month registered clinical trial, the authors aimed to determine whether it would be feasible to endoscopically ablate the lining of the gastric fundus to reduce ghrelin hormone production, gastric capacity, and weight. Ten patients underwent outpatient endoscopic ablation of their fundus lining, a procedure that took approximately one hour to complete under anesthesia. All patients went home the same day.

Six months after the procedure, the researchers found that patients had a significant reduction in plasma ghrelin levels (45 percent lower), meal capacity (42 percent smaller), hunger, appetite, and cravings. Patients also had increased confidence to resist overeating. The average patient lost 7.7 percent of their body weight, with half of the patients losing 10 percent or more of their body weight. There were no serious adverse events reported.